A growing number of investigators in leading research institutions and small and medium-sized companies are expanding from their strength in disease biology into early-stage drug discovery. However, this move requires successfully combining the disciplines of biochemistry, medicinal chemistry, pharmacokinetics and pharmacology, the breadth of which can present organisational, knowledge and competence challenges for institutions and investigators.

This interactive, lecture- and discussion-based course is held biennially and aims to give researchers of any discipline a broad introduction to the theoretical, practical and organisational aspects of small molecule drug discovery. Each topic will include a lecture together with discussion sessions and case histories to develop key aspects highlighted in the lectures. In addition there will be practical sessions to illustrate the beginnings of drug discovery programmes, including the production of target product profiles, compound progression criteria and scientific strategy.

Feedback from the 2014 course:
"The course covers everything on state-of-art drug discovery in the pharmaceutical industry. Completely relevant and excellent."
"The course provided an excellent introduction to many subject areas covered with further reading suggested for those
requiring more in depth information."
"I think this course was very comprehensive, it covered all the areas of drug discovery with excellent depth."
"Thank you very much for the opportunity to attend such a useful course."
"Thank you for a great experience during the course."

Application Deadline:

Already applied?
Login to your account.


Email the Course Organiser
(or call us: +44 (0)1223 496910)

Hashtag: #PASMDD2016